Development of Quality Indicators of Care for Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer Using a Delphi Process

Journal of Surgical Research

Volumn 156, Issue 1, 2009, Pages

  Dixon, Elijah ^a   Armstrong, Christopher ^a   Maddern, Guy ^b   Sutherland, Francis ^a   Hemming, Alan ^c   Wei, Alice ^d   Sherman, Morris ^d   Moore, Malcolm ^d   McKay, Andrew ^e   Urbach, David ^d   Labrie, Martin ^a   Gordon, Lee ^f   Barkun, Jeffrey ^g   Lynn Quan, May ^d   Dowden, Scot ^a   Bigam, David ^h   Gallinger, Steven ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f VANDERBILT UNIVERSITY   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

colorectal cancer; hepatic surgery; outcomes; quality indicators

Indexed keywords

ARTICLE; CANCER PATIENT; COLORECTAL CANCER; DELPHI STUDY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; LIVER METASTASIS; LIVER RESECTION; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SURGEON;

EID: 68649110226     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.03.084     Document Type: Article

References (25)

1. Campbell S.M., Roland M.O., and Buetow S.A. Defining quality of care. Soc Sci Med 51 (2000) 1611
2. Lohr K.N. Medicare: A strategy for quality assurance. J Qual Assur 13 (1991) 10
3. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q 44 Suppl (1966) 166
4. Clancy T.E., Dixon E., Perlis R., et al. Hepatic arterial infusion after curative resection of colorectal cancer metastases: A meta-analysis of prospective clinical trials. J Gastrointest Surg 9 (2005) 198
5. Scheele J., Stang R., Altendorf-Hofmann A., et al. Resection of colorectal liver metastases. World J Surg 19 (1995) 59
6. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309 discussion 318
7. Thirion P., Wolmark N., Haddad E., et al. Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: A re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer. Ann Oncol 10 (1999) 1317
8. Lee M.A., Byun J.H., Shim B.Y., et al. Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancer. Korean J Intern Med 20 (2005) 205
9. You Y.T., Changchien C.R., Huang J.S., et al. Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer. Int J Colorectal Dis 21 (2006) 33
10. Mann C.D., Metcalfe M.S., Leopardi L.N., et al. The clinical risk score: Emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 139 (2004) 1168
11. Bipat S., van Leeuwen M.S., Ijzermans J.N., et al. Evidence-base guideline on management of colorectal liver metastases in The Netherlands. Neth J Med 65 (2007) 5
12. Garden O.J., Rees M., Poston G.J., et al. Guidelines for resection of colorectal cancer liver metastases. Gut 55 Suppl 3 (2006) iii1
13. Walter L.C., Davidowitz N.P., Heineken P.A., et al. Pitfalls of converting practice guidelines into quality measures: Lessons learned from a VA performance measure. JAMA 291 (2004) 2466
14. Strasberg S.M., and Ludbrook P.A. Who oversees innovative practice? Is there a structure that meets the monitoring needs of new techniques?. J Am Coll Surg 196 (2003) 938
15. Jarnagin W.R., Gonen M., Fong Y., et al. Improvement in perioperative outcome after hepatic resection: Analysis of 1803 consecutive cases over the past decade. Ann Surg 236 (2002) 397 discussion 406
16. Belghiti J., Hiramatsu K., Benoist S., et al. Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 191 (2000) 38
17. Dimick J.B., Wainess R.M., Cowan J.A., et al. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 199 (2004) 31
18. Fink A., Kosecoff J., Chassin M., et al. Consensus methods: Characteristics and guidelines for use. Am J Public Health 74 (1984) 979
19. Gagliardi A.R., Fleshner N., Langer B., et al. Development of prostate cancer quality indicators: A modified Delphi approach. Can J Urol 12 (2005) 2808
20. Gagliardi A.R., Fung M.F., Langer B., et al. Development of ovarian cancer surgery quality indicators using a modified Delphi approach. Gynecol Oncol 97 (2005) 446
21. Gagliardi A.R., Simunovic M., Langer B., et al. Development of quality indicators for colorectal cancer surgery, using a 3-step modified Delphi approach. Can J Surg 48 (2005) 441
22. McGory M.L., Shekelle P.G., and Ko C.Y. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst 98 (2006) 1623
23. Guru V., Anderson G.M., Fremes S.E., et al. The identification and development of Canadian coronary artery bypass graft surgery quality indicators. J Thorac Cardiovasc Surg 130 (2005) 1257
24. Hannan E.L., Siu A.L., Kumar D., et al. The decline in coronary artery bypass graft surgery mortality in New York State. The role of surgeon volume. JAMA 273 (1995) 209
25. Begg C.B., Cramer L.D., Hoskins W.J., et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280 (1998) 1747